Thunder rule Holmgren out vs Kings due to back injury, but team remains undefeated despite key injuries.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
Thunder rule Holmgren out vs Kings due to back injury, but team remains undefeated despite key injuries.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.